LiveWire Ergogenics Signs Letter of Intent with Manufacturer and Distributor of CBD-Enriched Topicals
08 Août 2018 - 3:16PM
InvestorsHub NewsWire
Anaheim, CA --
August 8, 2018 -- InvestorsHub NewsWire -- LiveWire
Ergogenics, Inc. (OTC: LVVV), a company
focused on product development, acquisition and management of
legal, fully controlled and self-contained turnkey production
facilities for cannabis-based products and services, announced
today that it has signed a Letter of Intent with Sacred Biology, a
leading manufacturer of high-quality CBD-enriched lotions and
skin-care topicals.
In this all-stock
transaction LiveWire is entitled to acquire a minority interest in
the privately held Sacred Biology with a one-year option to
purchase 100% of the Company, once the transactions described in
the Letter of Intent are complete. LiveWire will be granted a seat
on the Sacred Biology management team and a member of Sacred
Biology’s management team will be named to the LiveWire Corporate
Advisory Board. In addition, LiveWire Ergogenics will immediately
be granted worldwide distribution rights for all current and future
Sacred Biology products.
“Our long-range
plans,” explains LiveWire CEO Bill Hodson, “include developing and
thoroughly testing our unique cannabis strains for use in medical
cannabis products, targeting specific ailments for large “sufferer”
populations, and producing and licensing various white-label
products for customers around the world. To support these efforts,
we are also expanding the reach of our 7X Pure Cannabis Compliance
and Dosage Verification System. Sacred Biology’s extensive
experience in manufacturing CBD product lines is a perfect fit to
expedite the development of these LiveWire projects. In addition,
the National Distributorship for the Sacred Biology products will
allow LiveWire to generate significant additional top line
revenue.”
Sacred Biology will
also manufacture and distribute “Capsadiol”, LiveWire’s proprietary
cream, composed of capsaicin infused with cannabinoids. Like
capsaicin, cannabinoids have a documented perceived effectiveness
in treating various issues, such as chronic pain, inflammation,
skin disorders, headaches, and nausea, among others. With the
increasing demand for naturally derived alternatives, coupled with
the rise and acceptance of cannabinoid use for medical purposes,
now is a promising time to marry the two products to fight pain
naturally. This will be a main focus moving forward to develop
muscle rubs and other pain alleviating products as the population
ages.
Katie Devoe, Founder
and CEO of Sacred Biology, states, “We are very excited about the
opportunity to partner with LiveWire Ergogenics. We look forward to
working with LiveWire’s horticulture team to produce new topical
and skin care products for the medical and cosmetics
markets.”
LiveWire’s two-stage
approach to the potential 100% acquisition of Sacred Biology will
enable the Company to conduct thorough due-diligence before
exercising the full purchase
option.
For more information
about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For non-material
updates, follow LiveWire Ergogenics on Twitter
@livewireLVVV.
About LiveWire
Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying
and monetizing current and future trends in the health and wellness
industry, including the design and establishment of legal, fully
controlled and contained cannabis production environments. To
further this agenda, the Company is entering into select research
partnerships to explore the application of cannabinoid-based
products to target specific ailments or conditions with large
“sufferer” populations, for human and veterinarian applications.
This includes the development and licensing of high-quality
cannabinoid-based products and services, the cloning of cannabis
strains to produce positive medicinal results and the dosing
verification of zero pesticide products for quality brands via its
“7X-Pure Dosage and Verification System”. The team at LiveWire
Ergogenics is committed to generating and implementing innovative
ideas to produce high-quality products that satisfy an increasing
demand in this fast-growing
industry.
The
company does not sell or distribute any products anywhere that are
in violation of the United States Controlled Substance Act and will
only work with or have ownership in companies that are in complete
compliance with Federal and State laws and have the required
permits to operate. The team at LiveWire Ergogenics has a passion
for research and advanced product development and is committed to
generating and implementing innovative ideas to produce
high-quality products that satisfy the increasing demand in this
fast-growing industry.
LIVEWIRE ERGOGENICS
INC.
1600 North Kraemer
Blvd.
Anaheim, CA
92806
714-740-5144
www.livewireergogenics.com
info@livewireergogenics.com
Livewire Ergogenics (PK) (USOTC:LVVV)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Livewire Ergogenics (PK) (USOTC:LVVV)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about Livewire Ergogenics Inc (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Livewire Ergogenics, Inc. (PC)